A Comparison Between the Minimal Model and the Glucose Clamp in the Assessment of Insulin Sensitivity Across the Spectrum of Glucose Tolerance

An insulin-modified frequently sampled intravenous glucose tolerance test (FSIGTT) with minimal model analysis was compared with the glucose clamp in 11 subjects with normal glucose tolerance (NGT), 20 with impaired glucose tolerance (IGT), and 24 with non-insulin-dependent diabetes mellitus (NIDDM). The insulin sensitivity index (SI) was calculated from FSIGTT using 22- and 12-sample protocols (SI(22) and SI(12), respectively). Insulin sensitivity from the clamp was expressed as SI(clamp) and SIP(clamp). Minimal model parameters were similar when calculated with SI(22) and SI(12). SI could not be distinguished from 0 in ∼ 50% of diabetic patients with either protocol. SI(22) correlated significantly with SI(clamp) in the whole group (r = 0.62), and in the NGT (r = 0.53), IGT (r = 0.48), and NIDDM (r = 0.41) groups (P < 0.05 for each). SI(12) correlated significantly with SI(clamp) in the whole group (r = 0.55, P < 0.001) and in the NGT (r = 0.53, P = 0.046) and IGT (r = 0.58, P = 0.008) but not NIDDM (r = 0.30, P = 0.085) groups. When SI(22), SI(clamp), and SIP(clamp) were expressed in the same units, SI(22) was 66 ± 5% (mean ± SE) and 50 ± 8% lower than SI(clamp) and SIP(clamp), respectively. Thus, minimal model analysis of the insulin-modified FSIGTT provides estimates of insulin sensitivity that correlate significantly with those from the glucose clamp. The correlation was weaker, however, in NIDDM. The insulin-modified FSIGTT can be used as a simple test for assessment of insulin sensitivity in population studies involving nondiabetic subjects. Additional studies are needed before using this test routinely in patients with NIDDM.

[1]  I. Hramiak,et al.  A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. , 1990, The Journal of clinical endocrinology and metabolism.

[2]  R C Boston,et al.  A modified minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in insulin-dependent diabetes. , 1991, Metabolism: clinical and experimental.

[3]  R N Bergman,et al.  Estimation of Endogenous Glucose Production During Hyperinsulinemic-Euglycemic Glucose Clamps: Comparison of Unlabeled and Labeled Exogenous Glucose Infusates , 1987, Diabetes.

[4]  P. Savage,et al.  Insulin and atherosclerosis: villain, accomplice, or innocent bystander? , 1993, British heart journal.

[5]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[6]  G. Reaven,et al.  Enhanced Glucose Utilization During Prolonged Glucose Clamp Studies , 1981, Diabetes.

[7]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[8]  R N Bergman,et al.  The Insulin Sensitivity Index in Nondiabetic Man: Correlation Between Clamp-derived and IVGTT-derived Values , 1986, Diabetes.

[9]  R. Rizza,et al.  Effects of Plasma Glucose Concentration on Glucose Utilization and Glucose Clearance in Normal Man , 1981, Diabetes.

[10]  G. Reaven,et al.  Evidence for an independent relationship between insulin resistance and fasting plasma HDL‐cholesterol, triglyceride and insulin concentrations , 1992, Journal of internal medicine.

[11]  R N Bergman,et al.  Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. , 1987, The Journal of clinical investigation.

[12]  R N Bergman,et al.  MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. , 1986, Computer methods and programs in biomedicine.

[13]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[14]  Richard N Bergman,et al.  Reduced Sample Number for Calculation of Insulin Sensitivity and Glucose Effectiveness From the Minimal Model: Suitability for Use in Population Studies , 1993, Diabetes.

[15]  G. Reaven,et al.  Relationship Between Fasting Plasma Insulin Level and Resistance to Insulin-Mediated Glucose Uptake in Normal and Diabetic Subjects , 1973, Diabetes.

[16]  C Cobelli,et al.  Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. , 1986, The American journal of physiology.

[17]  R N Bergman,et al.  Modified protocols improve insulin sensitivity estimation using the minimal model. , 1987, The American journal of physiology.

[18]  S. Lillioja,et al.  Relationship between degree of obesity and in vivo insulin action in man. , 1985, The American journal of physiology.

[19]  D. Owens,et al.  Reduced Sampling Protocols in Estimation of Insulin Sensitivity and Glucose Effectiveness Using the Minimal Model in NIDDM , 1993, Diabetes.

[20]  G. Reaven Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[21]  S. Kahn,et al.  Effect of heparin on insulin-glucose interactions measured by the minimal model technique: implications for reproducibility using this method. , 1993, Metabolism: clinical and experimental.

[22]  J D Best,et al.  Glucose Disposal is Not Proportional to Plasma Glucose Level in Man , 1981, Diabetes.

[23]  R. Bergman,et al.  A Minimal-Model-Based Glucose Clamp Yielding Insulin Sensitivity Independent of Glycemia , 1982, Diabetes.

[24]  M. Laakso,et al.  Asymptomatic atherosclerosis and insulin resistance. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[25]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.

[26]  G. Reaven Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[27]  K. Tokuyama,et al.  Pathogenic Factors Responsible for Glucose Intolerance in Patients With NIDDM , 1992, Diabetes.

[28]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[29]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[30]  R N Bergman,et al.  Assessment of insulin sensitivity in vivo. , 1985, Endocrine reviews.

[31]  W. Sheu,et al.  Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  G. Reaven,et al.  Relationship Between the Plasma Insulin Response to Oral Glucose and Insulin-stimulated Glucose Utilization in Normal Subjects , 1984, Diabetes.

[33]  R N Bergman,et al.  Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. , 1990, The Journal of clinical endocrinology and metabolism.

[34]  G. Reaven,et al.  Effect of time on measurement of hepatic glucose production. , 1988, The Journal of clinical endocrinology and metabolism.

[35]  M. Saad,et al.  Insulin resistance in essential hypertension. , 1990, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.